| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.075 | 0.1 |